Effect of Lower Extremity Modified Constraint-induced Movement Therapy on Locomotion in Children With Hemiplegia
Key facts
- Where
- Cairo, EgyptSee the site
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 6 and 8 years old?
Source: NCT07686809, who can take part
Where in Egypt
- outpatient clinic faculty of physical therapy, Cairo UniversityCairo, EgyptContact: Mohamed Ali TahaTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorTrial details
- Who runs it
- Cairo University
- Trial code
- NCT07686809
- Record updated
- 7 July 2026
- Original description
* To determine the effect of modified constraint-induced movement therapy on spatial and temporal gait parameters in children with hemiplegia. * To determine the effect of modified constraint-induced movement therapy on functional mobility in children with hemiplegia.Read full original descriptionShow less
* To determine the effect of modified constraint-induced movement therapy on spatial and temporal gait parameters in children with hemiplegia. * To determine the effect of modified constraint-induced movement therapy on functional mobility in children with hemiplegia.
Inclusion: The age of the selected children will range from 6 to 8 years old; Degree of spasticity will range from 1+ to 2 according to the modified Ashworth scale; The level of motor function of the children will be levels I-II according to the Gross Motor Function Classification System; Participants will present a score between 41 to 56 points on the pediatric balance scale; They will be able to follow instructions and understand commands.
Exclusion: Lung and heart diseases and disorders; Children with epilepsy; Bone and tendon lengthening surgeries within the last 6 months; Vision or hearing problems; Children with fixed deformities in the lower extremity; Recent intramuscular Botulinum toxin injection.